| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0073 | 1 |